MedPlus Health Services Files SEBI Compliance Certificate for Q4FY26
MedPlus Health Services Limited filed its mandatory SEBI Regulation 74(5) compliance certificate for Q4FY26 on April 06, 2026. The certificate, issued by registrar KFIN Technologies Limited, confirms proper submission of securities dematerialization and rematerialization details to stock exchanges BSE and NSE, as well as depositories NSDL and CDSL. The documentation ensures full regulatory compliance for the quarter ended March 31, 2026, with certificates available on company and exchange websites.
*this image is generated using AI for illustrative purposes only.
Medplus health services Limited has completed its regulatory filing requirements by submitting the mandatory compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The pharmaceutical retail chain fulfilled its quarterly compliance obligations through proper documentation and filing procedures.
Regulatory Compliance Filing
The company filed the required certificate with stock exchanges on April 06, 2026, through Company Secretary and Compliance Officer Manoj Kumar Srivastava. The filing ensures adherence to SEBI (Depositories and Participants) Regulations, 2018, specifically under Regulation 74(5) requirements.
| Filing Details: | Information |
|---|---|
| Filing Date: | April 06, 2026 |
| Quarter Covered: | March 31, 2026 |
| Regulation: | SEBI Regulation 74(5) |
| Filed By: | Manoj Kumar Srivastava, Company Secretary |
Stock Exchange Submissions
MedPlus Health Services submitted the compliance documentation to both major Indian stock exchanges where its shares are listed. The certificates were addressed to the listing departments of BSE Limited and National Stock Exchange of India Limited, ensuring comprehensive regulatory coverage.
| Exchange Details: | Information |
|---|---|
| BSE Scrip Code: | 543427 |
| NSE Symbol: | MEDPLUS |
| BSE Address: | Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai |
| NSE Address: | Exchange Plaza, Bandra Kurla Complex, Mumbai |
Registrar Certification Process
KFIN Technologies Limited, serving as the company's Registrar and Transfer Agent, issued the compliance certificates on April 01, 2026. Deputy Vice President Bhaskar Roy signed the certificates confirming that securities dematerialization and rematerialization details were properly furnished to stock exchanges during the specified quarter.
Depository Compliance
The registrar submitted identical certificates to both major depositories in India - National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). These submissions ensure complete compliance across the entire securities infrastructure ecosystem.
| Depository Information: | Details |
|---|---|
| NSDL Address: | Trade World, Kamala Mills Compound, Mumbai |
| CDSL Address: | Marathon Futurex, NM Joshi Marg, Mumbai |
| Certificate Date: | April 01, 2026 |
| Issued By: | KFIN Technologies Limited |
Document Availability
The compliance certificates are accessible through multiple channels for stakeholder reference. The company has made the documentation available on its official website at www.medplusindia.com , along with the websites of BSE Limited and National Stock Exchange of India Limited for transparent access to regulatory filings.
Historical Stock Returns for Medplus Health Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.34% | -0.13% | -0.79% | +12.32% | +10.63% | -25.68% |
How might MedPlus's consistent regulatory compliance track record impact investor confidence and institutional investment flows in the upcoming quarters?
What strategic expansion plans could MedPlus be preparing for, given their focus on maintaining strong regulatory frameworks?
Will the pharmaceutical retail sector face increased regulatory scrutiny that could affect MedPlus's operational costs and compliance burden?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
